Temperature-sensitive mutations for live-attenuated Rift Valley fever vaccines: Implications from other RNA viruses

Shoko Nishiyama, Tetsuro Ikegami

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Rift Valley fever (RVF) is a mosquito-borne zoonotic disease endemic to the African continent. RVF is characterized by high rate of abortions in ruminants and hemorrhagic fever, encephalitis or blindness in humans. RVF is caused by the Rift Valley fever virus (RVFV: genus Phlebovirus, family Bunyaviridae). Vaccination is the only known effective strategy to prevent the disease, but there are no licensed RVF vaccines available for humans. A live-attenuated vaccine candidate derived from the wild-type pathogenic Egyptian ZH548 strain, MP-12, has been conditionally licensed for veterinary use in the United States. MP-12 displays a temperature-sensitive (ts) phenotype and does not replicate at 41°C. The ts mutation limits viral replication at a specific body temperature and may lead to an attenuation of the virus. Here we will review well-characterized ts mutations for RNA viruses, and further discuss the potential in designing novel live-attenuated vaccines for RVF.

Original languageEnglish (US)
Article number787
JournalFrontiers in Microbiology
Volume6
Issue numberJUL
DOIs
StatePublished - 2015

Fingerprint

Rift Valley Fever
RNA Viruses
Vaccines
Mutation
Temperature
Attenuated Vaccines
Phlebovirus
Rift Valley fever virus
Bunyaviridae
Induced Abortion
Zoonoses
Ruminants
Encephalitis
Blindness
Culicidae
Body Temperature
Vaccination
Fever
Viruses
Phenotype

Keywords

  • Bunyavirus
  • MP-12
  • Rift Valley fever virus
  • Temperature sensitivity
  • Vaccine

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

@article{5b121a4227c04c6fa8e824b93b5f20ca,
title = "Temperature-sensitive mutations for live-attenuated Rift Valley fever vaccines: Implications from other RNA viruses",
abstract = "Rift Valley fever (RVF) is a mosquito-borne zoonotic disease endemic to the African continent. RVF is characterized by high rate of abortions in ruminants and hemorrhagic fever, encephalitis or blindness in humans. RVF is caused by the Rift Valley fever virus (RVFV: genus Phlebovirus, family Bunyaviridae). Vaccination is the only known effective strategy to prevent the disease, but there are no licensed RVF vaccines available for humans. A live-attenuated vaccine candidate derived from the wild-type pathogenic Egyptian ZH548 strain, MP-12, has been conditionally licensed for veterinary use in the United States. MP-12 displays a temperature-sensitive (ts) phenotype and does not replicate at 41°C. The ts mutation limits viral replication at a specific body temperature and may lead to an attenuation of the virus. Here we will review well-characterized ts mutations for RNA viruses, and further discuss the potential in designing novel live-attenuated vaccines for RVF.",
keywords = "Bunyavirus, MP-12, Rift Valley fever virus, Temperature sensitivity, Vaccine",
author = "Shoko Nishiyama and Tetsuro Ikegami",
year = "2015",
doi = "10.3389/fmicb.2015.00787",
language = "English (US)",
volume = "6",
journal = "Frontiers in Microbiology",
issn = "1664-302X",
publisher = "Frontiers Media S. A.",
number = "JUL",

}

TY - JOUR

T1 - Temperature-sensitive mutations for live-attenuated Rift Valley fever vaccines

T2 - Implications from other RNA viruses

AU - Nishiyama, Shoko

AU - Ikegami, Tetsuro

PY - 2015

Y1 - 2015

N2 - Rift Valley fever (RVF) is a mosquito-borne zoonotic disease endemic to the African continent. RVF is characterized by high rate of abortions in ruminants and hemorrhagic fever, encephalitis or blindness in humans. RVF is caused by the Rift Valley fever virus (RVFV: genus Phlebovirus, family Bunyaviridae). Vaccination is the only known effective strategy to prevent the disease, but there are no licensed RVF vaccines available for humans. A live-attenuated vaccine candidate derived from the wild-type pathogenic Egyptian ZH548 strain, MP-12, has been conditionally licensed for veterinary use in the United States. MP-12 displays a temperature-sensitive (ts) phenotype and does not replicate at 41°C. The ts mutation limits viral replication at a specific body temperature and may lead to an attenuation of the virus. Here we will review well-characterized ts mutations for RNA viruses, and further discuss the potential in designing novel live-attenuated vaccines for RVF.

AB - Rift Valley fever (RVF) is a mosquito-borne zoonotic disease endemic to the African continent. RVF is characterized by high rate of abortions in ruminants and hemorrhagic fever, encephalitis or blindness in humans. RVF is caused by the Rift Valley fever virus (RVFV: genus Phlebovirus, family Bunyaviridae). Vaccination is the only known effective strategy to prevent the disease, but there are no licensed RVF vaccines available for humans. A live-attenuated vaccine candidate derived from the wild-type pathogenic Egyptian ZH548 strain, MP-12, has been conditionally licensed for veterinary use in the United States. MP-12 displays a temperature-sensitive (ts) phenotype and does not replicate at 41°C. The ts mutation limits viral replication at a specific body temperature and may lead to an attenuation of the virus. Here we will review well-characterized ts mutations for RNA viruses, and further discuss the potential in designing novel live-attenuated vaccines for RVF.

KW - Bunyavirus

KW - MP-12

KW - Rift Valley fever virus

KW - Temperature sensitivity

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=84938862261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938862261&partnerID=8YFLogxK

U2 - 10.3389/fmicb.2015.00787

DO - 10.3389/fmicb.2015.00787

M3 - Article

AN - SCOPUS:84938862261

VL - 6

JO - Frontiers in Microbiology

JF - Frontiers in Microbiology

SN - 1664-302X

IS - JUL

M1 - 787

ER -